SPEAKERS

 

Dr Dicky Abraham, Executive Director, Project Leadership Group, Global Vaccine and Biologics Commercialization, Merck

Dr Carl Alving, Former Chief of Adjuvant and Antigen Research & Emeritus Senior Scientist, Walter Reed Army Institute Of Research

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

Marty Anderson, Executive Director, Clinical Development - GenMed, INC Research/inVentiv Health

Marty Anderson at World Vaccine Congress Washington 2018

Dr Bo Arve, Executive Director, Pfizer Inc

Dr Bo Arve at World Vaccine Congress Washington 2018

Prof Fikri Avci, Academy, UGA Center for Molecular Medicine

Dr Ripley Ballou, VP & Head, GSK Global Vaccines US R&D Center, GSK Vaccines

Dr Ripley Ballou at World Vaccine Congress Washington 2018

Ms Emily Bancroft, Acting President, VillageReach

Dr Eliav Barr, Senior Vice President, Infectious Diseases Global Clinical Development, Merck Research Laboratories

Dr Eileen Barry, Professor of Medicine, University of Maryland School of Medicine

Dr Samik Basu, Director of Translational Sciences, Adaptimmune Llc

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Dr Wolfgang Bender, Chief Medical Officer, Valneva

Franck Berthe, Senior Livestock Specialist, The World Bank

Dr Jay A. Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr Nina Bhardwaj, Director of Immunotherapy Professor of Medicine, Division of Hematology & Oncology, Tisch Cancer Institute

Dr Todd Black, Executive Director, Infectious Diseases, Merck Research Laboratory

Dr Steven Black, Professor of Pediatrics, Center for Global Health, University of Cincinnati Children’s Hospital in Ohio

Dr Bahram Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics

Dr Karin Bok, Senior Vaccine Science Advisor, US Department of Health and Human Services

Prof Louis Bont, Chairman, ReSViNET

Dr Ezio Bonvini, CSO, MacroGenics, Inc.

Dr Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine

Dr Karen Broder, Medical Officer, US Centers for Disease Control and Prevention

Jennifer Brogdon, Director of Exploratory Immuno Oncology, N.I.B.R.

Matthew Burt, Vaccine Supply Chain Director,, Pfizer

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences

Dr Andrea Carfi, Senior Director, Antigen Design and Project Leader, Valera LLC

Dr Andrea Carfi at World Vaccine Congress Washington 2018

Dr Corey Casper, Chief Scientific Officer, Infectious Disease Research Institute

Andrew Catchpole, Scientific and Operations Director, hVIVO

Dr Sumana Chandramouli, Laboratory Head, Preclinical R&D, GSK Vaccines

Dr Sumana Chandramouli at World Vaccine Congress Washington 2018

James Cheyne, Independent Supply Chain Consultant Co-Founder of WHO's Cold Chain Unit, Health Service Logistics

Dr Roman Chicz, Associate Vice President and Global Head Of External Research and Development, Sanofi Pasteur

Dr Giuseppe Ciaramella, Chief Scientific Officer, Valera LLC

Dr Michael Ciesielski, Assistant Professor of Neurosurgery & Oncology, Roswell Park Cancer Institute

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Ms Rebecca Coyle, Executive Director, American Immunization Registry Association

Dr Alan Cross, Professor of Medicine, University of Maryland School of Medicine

Dr James Crowe, Director of Vanderbilt Vaccine Center, Vanderbilt Vaccine Center

Dr Ildiko Csiki, Vice President - Clinical Development, Inovio Pharmaceuticals

Dr Margie Danchin, Paediatrcian and Senior Research Fellow, Murdoch Children's Research Institute, Royal Children's Hospital

Giuseppe Del Giudice, Translational Science Leader, GSK Vaccines

Dr Philippe Denoel, Director of External R and D, Innovation, Scientific Affairs and Opportunities Collaborations for Public Funding, GSK Vaccines

Dr Philippe Denoel at World Vaccine Congress Washington 2018

Dr Arnaud Didierlaurent, Head Adjuvant Platform, GSK Vaccines

Dr Arnaud Didierlaurent at World Vaccine Congress Washington 2018

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Dr Ruben Donis, Deputy Director of the Division of Influenza and Emerging Infectious Diseases, HHS - ASPR - BARDA

Dr Philip Dormitzer, Head for U.S. Research, Global Head of Virology and Vice President, Novartis Vaccines

Dr Cynthia Dukes, Vice President - Global Project Management, ICON

Dr Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, The Bill & Melinda Gates Foundation

Nima Farzan, Chief Executive Officer, PaxVax Inc

Nima Farzan at World Vaccine Congress Washington 2018

Heinz Feldmann, Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section, NIH

Amy Finan, Chief Executive Officer, Sabin Vaccine Institute

Dr Veronica Gambillara Fonck, Co-Founder & Chief Executive Officer, LimmaTech Biologics AG

Dr Cyril G Gay, Senior National Program Leader, A.R.S. National Programs

Parrish Galliher, Chief Technology Officer, GE Healthcare

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Professor Thomas Geisbert, Professor Microbiology and Immunology, University of Texas Medical Branch

Dr Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

Dr Don Gerson, CEO, Pnuvax Inc

Dr Jens Gertow, Scientific Advisor, Mabtech

Dr Jens Gertow at World Vaccine Congress Washington 2018

Dr Brad Gessner, VP for Scientific Affairs at AMP, Faculty at U. Maryland/Centers for Vaccine Development & VP and Director, Global Pneumococcal, Pfizer

Dr Basav Ghosh, Sr. Director, Pfizer

Jeremy Gillespie, Global sales Director, Kerry Sheffield

Jeremy Gillespie at World Vaccine Congress Washington 2018

Dr Ann Ginsberg, Chief Medical Officer, AERAS

Geoffrey Glauser, Senior Consultant Supply Chain, HHS - ASPR - BARDA

Dr Gregory Glenn, President, Research and Development, Novavax

Dr Barney Graham, Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

Dr Duane J Gubler, Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Graduate Medical School

Dr Nir Hacohen, Director of the Center for Cancer Immunology and Co-Director of the Center for Cell Circuits, Broad Institute and Massachusetts General Hospital

Dr Neal Halsey, Professor of International Health, Director of the Institute for Vaccine Safety, Johns Hopkins

Dr Scott Halstead, Adjunct Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences

Dr Ahd Hamidi, Project Director, Batavia Biosciences

Paddy Hanlon, V.P. Global Key Accounts, Marken

Dr Mazen Hassanain, Founder, SaudiVax

Richard Hatchett, CEO, CEPI

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organization

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited

Dr Peter Hotez, Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Center, Baylor College of Medicine

Dr Ken Ishii, Professor and Project Leader, Osaka U.i

Dr Hector Izurieta, Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER, U.S. Federal Drug Administration

Julie Jacobson, Senior Program Officer, Neglected Tropical Diseases, The Bill & Melinda Gates Foundation

Dr Jorge Kalil, Former director of Butantan Institute, Professor and Head Clinical Immunology, School of Medicine, University Of Sao Paulo

Dr Jorge Kalil at World Vaccine Congress Washington 2018

Dr Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly and Company

Kemal Karaca, Director, Elanco Animal Health

Dr Erin Karski, Associated Medical Director, Genentech

Peter Khoury, CEO, Nanotherapeutics Inc

Peter Khoury at World Vaccine Congress Washington 2018

Wayne C Koff, President and CEO, The Human Vaccines Project

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis

Dr Peter Kwong, Chief, Structural Biology Section, NIH

Dr Rhonda LaFleur, Principal Scientist, Merck Animal Health

Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V.

Dr Heidi Larson, Professor of Anthropology, Risk and Decision Science, London School of Hygiene and Tropical Medicine

Dr Stéphane Lemiere, Global Director of Technical Services, Boehringer Ingelheim France

Dr Myron M. Levine, Grollman Distinguished Professor and Director, Center for Vaccine Development, University of Maryland School of Medicine

Dr Hyam Levitsky, Executive Vice President and Chief Scientific Officer, Juno Therapeutics

Dr Fiona Lin, Small Molecule Analytical Chemistry and Quality Control, Genentech

Thomas Lingelbach, President and Chief Executive Officer, Valneva SE

Dr Ira Longini, Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida

Dr Robin Löving, CSO, Salipro Biotech AB

Dr Robin Löving at World Vaccine Congress Washington 2018

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc.

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi

Prof James Moon, Assistant Professor of Biomedical Informatics, University of Michigan

Dr Martin Moore, Associate Professor, Interim Director of Research, Pediatric Infectious Diseases, Emory University Children’s Center

Dr Vasee Moorthy, Coordinator, Research, Ethics, Knowledge Uptake, Department of Information, Evidence and Research, & Team Leader, R&D Blueprint, World Health Organisation

Dr Alex Morrow, Chair of the International Research Consortium, STAR-IDAZ International Research Consortium on Animal Health

Dr Sally Mossman, VP, Head Discovery Performance Unit, US, GSK Vaccines

Wilhelm (Willie) Muehlhausen, VP eCOA & Innovation, ICON Clinical Research

Wilhelm (Willie) Muehlhausen at World Vaccine Congress Washington 2018

Dr Gary Nabel, Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi

Stephen Nagler, Executive Director, MedPro Investors LLC

Stephen Nagler at World Vaccine Congress Washington 2018

Dr Eszter Nagy, Co-Founder, President and CSO, Arsanis Inc

Dr Paul Offit, Chief of Infectious Diseases, & Director of the Vaccine Education Center, Childrens Hospital of Pennsylvania

Dr Derek O'Hagan, Global Head of Discovery Support and New Technology, GSK Vaccines

Dr Saad B Omer, William H. Foege Professor of Global Health Professor of Epidemiology & Pediatrics, Emory University - School of Medicine

Dr Walter A Orenstein, Professor and Associate Director, Emory Vaccine Center Emory University

Dr Justin R Ortiz, Affiliate Assistant Professor, Global Health, Affiliate Assistant Professor, Medicine Medical Officer, Initiative for Vaccine Re, WHO

Professor Klaus Osterrieder, Managing Director, Institute of Virology, Department of Veterinary Medicine, Freie Universitt Berlin

Dr Drew Pardoll, Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy Professor of Oncology, John Hopkins University

Dr Viliam Pavliak, Head of Vaccine Development, International Vaccine Institute

Dr Viliam Pavliak at World Vaccine Congress Washington 2018

Dr Patricia Pietrobon, Associate Vice President, R&D, Cdiff Program Leader, Sanofi Pasteur

Dr Lisa Plitnick, Senior Principal Investigator, Pre-Clinical Vaccine Safety,, Merck

Dr Lisa Plitnick at World Vaccine Congress Washington 2018

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Frederick Porter, Senior Director of Product Development, Duke Human Vaccine Institute

Dr Andrew Potter, CEO, VIDO-InterVac

Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious Diseases and Vaccines, MedImmune Inc

Dr Hari Pujar, Vice President Technical Development and Manufacturing, Moderna Therapeutics

Dr Fred Ramsdell, Vice President, Research, Parker Institute for Cancer Immunotherapy

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines

Dr Steven Reed, President, Founder & CEO, Infectious Disease Research Institute

Dr Robert Reiner, Assistant Professor, Global Health, University Of Washington

Dr Robert Reiner at World Vaccine Congress Washington 2018

Dr Arthur Reingold, Professor and Division Head Epidemiology, Former ACIP Member, UC Berkeley School of Public Health

Felix Rey, Head of Structures, Institut Pasteur

Felix Rey at World Vaccine Congress Washington 2018

Dr Margo R. Roberts, Chief Scientific Officer, Kite Pharma Inc

Dr Simona Rondini, Vaccine Development Lead, COPD Vaccine, GSK Vaccines

Dr Simona Rondini at World Vaccine Congress Washington 2018

Jeffrey Rowland, Director, Global Operational Partnerships, Gavi, The Vaccine Alliance

Dr Dorit Rubinstein Reiss, Professor of Law, UC Hastings College of the Law

Rodrigo Ruiz, Head of Country Pharmacovigilance Mexico, Bristol-Myers Squibb De Mexico

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Wendy Saffell-Clemmer, Director - Research, Baxter BioPharmaceutical Solutions

Dr Daniel Salmon, Prof Global Disease Epidemiology and Control; Deputy Director JHU’s Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Surya Sankuratri, Executive Director, Merck

Surya Sankuratri at World Vaccine Congress Washington 2018

Dr Mathuram Santosham, Professor, Johns Hopkins University

Dr Mathuram Santosham at World Vaccine Congress Washington 2018

Beate Schmoele-Thoma, Clinical Lead, RSV, Pfizer

Beate Schmoele-Thoma at World Vaccine Congress Washington 2018

Michael A. Schrader, Co-Founder and Chief Executive Officer, Vaxess Technologies, Inc

Dr Jason Schwartz, Assistant Professor of Health Policy, Yale School of Public Health

Dr Robert Seder, Chief of the Cellular Immunology Section, N.I.A.I.D. N.I.H.

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences

Dr Alessandro Sette, Professor, Head and Member, La Jolla Infectious Disease Institute

Dr Angela Shen, CAPT, US Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office, U.S. Department of Health & Human Services

Pei-Yong Shi, Kempner Professor of Human Genetics, University of Texas Medical Branch

Dr Sushma Shivaswamy, Vice President, Research and Development, XBiotech

Dr Rahul Singhvi, Chief Operating Officer, Takeda Vaccines

B.T. Slingsby, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund

B.T. Slingsby at World Vaccine Congress Washington 2018

Dr David L. Smith, Professor in the Department of Epidemiology, Johns Hopkins and the Center for Disease Dynamics

Stacy Sneeringer, Senior Research Economist, Economic Research Service United States Department of Agriculture USDA

Dr Max Søgaard, Director of Process Development, Expres2Ion Biotechnologies

Thomas Sorensen, Regional Chief, Supply and Procurement, Unicef

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services

Dr Erin Spiegel, Regulatory Affairs Manager, PharmaJet

Dr Uwe Staerz, Chief Scientific Officer Chairman, Greffex Inc

Dr Jens-Ulrich Stegmann, Vice President Head Clinical Safety and Pharmacovigilance, GlaxoSmithKline Biologicals

Mr Robert Steinglass, Director, Immunization Center, John Snow Inc

Dr Dan Stinchcomb, CSO, Infectious Disease Research Institute

Dr Jeffrey Stoddard, US Medical Affairs Lead for Zoster Vaccine, GSK Vaccines

Dr Jeffrey Stoddard at World Vaccine Congress Washington 2018

Dr Walter Straus, Associate Vice President, Therapeutic Area Head, Clinical Safety and Risk Management, Merck And Company

Dr Darrel Styles, Senior Staff Veterinarian, U.S.D.A. A.P.H.I.S. Veterinary Services

Dr Kena Swanson, Senior Principle Scientist, Research Lead, RSV, Pfizer

Dr Kena Swanson at World Vaccine Congress Washington 2018

Dr Erich Tauber, Chief Executive Officer and Founder, Themis Bioscience

Samuel Thevasagayam, Deputy Director, Global Development, The Bill & Melinda Gates Foundation

Samuel Thevasagayam at World Vaccine Congress Washington 2018

Dr Marta Tomasi, Post-doc researcher, Free University of Bozen Bolzano

Steven Townson, Principal Scientist, Clinical Research Oncology Early Development, Merck & Co Inc

Dr Vu Truong, Founder, Chief Executive Officer and Director, Aridis Pharmaceuticals

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines

Dr Matthias Von Herrath, Professor in Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology

Dr Thomas W Scott, Distinguished Professor, University of California Davis

Dr Brian Ward, Medical Officer, Medicago

Jim Wassil, Vice President, Business Unit Lead, Vaccines, Global Health and Value, Pfizer

Laurie Werner, Global Director, BID Initiative, PATH

Dr Stephen Whitehead, Senior Associate Scientist, NIAID

Dr Stephen Whitehead at World Vaccine Congress Washington 2018

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Edward Wilson, Director, Center for Health Logistics, John Snow Inc

Dr Ashley Wivel, Executive Director, Global Clinical Safety and Risk Management, Global Safety Physician for Ebola Vaccine Program, Merck Research Laboratories

Dr Yan-ping Yang, Senior Director, Head of Bioprocess R&D North America, Sanofi Pasteur

Alan Young, CSO, Medgene Labs

Darin Zehrung, Portfolio Leader of Vaccine and Pharmaceutical Delivery Technologies and Senior Technical Officer, Path

Dr Robert Zolynas, Vice President, Bayer Animal Health